COVID-19 Pandemic May Shed Light on Better Treatments for Substance Use Disorder

Interventions like telemedicine and virtual support groups have exploded in response to social distancing. Now researchers can fully measure how well these interventions work. Research about how the COVID-19 pandemic affects people with substance use disorder (SUD) can inform strategies for providing treatment and social support in a post-pandemic world, said Nora Volkow, M.D., director

Continue Reading

APA Experts Urge Congress to Continue Relaxed Telehealth Regulations Post-Pandemic

During a virtual congressional briefing last month, APA President Jeffrey Geller, M.D., M.P.H., and members of APA’s Committee on Telepsychiatry emphasized the need for expanded access to mental health care through telehealth not only during the COVID-19 pandemic, but afterward as well. The briefing, titled “Collective Crisis: Preparing for America’s Next Wave of Mental Health

Continue Reading

Ketamine’s Antidepressant Effect May Depend on Opioid System

Previous studies of ketamine have focused on glutamate, but the new finding showing activation of opioid receptors shows why repeated use of ketamine may produce tolerance and addiction. The antidepressant effects of ketamine appear to depend on activation of the brain’s opioid receptors, underscoring the drug’s addictive potential, according to a report published this week

Continue Reading